<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-042924</identifier>
<setSpec>0214-3429</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Implication of ermX genes in macrolide- and telithromycin- resistance in Corynebacterium jeikeium and Corynebacterium amycolatum</dc:title>
<dc:description xml:lang="en">The activity of seven macrolides, clindamycin and telithromycin against clinical isolates of Corynebacterium spp. was studied. Of these, 36isolates were identified as C. jeikeium and 57 as C. amycolatum. The frequency of resistance to erythromycin and other macrolides as wellas clindamycin was high, with CMI90 &gt;256 ìg/ml. Telithromycin showed the best activity, with 52.3% of C. amycolatum and 70% of C. jeikeiumerythromycin-resistant strains susceptible to this ketolide. All strains had the MLSb constitutive phenotype. The ermX gene was presentin all erythromycin-resistant strains, and in C. amycolatum was 100% homologous with that of C. striatum and C. diphtheriae</dc:description>
<dc:creator>Yagüe Guirao, G</dc:creator>
<dc:creator>Valero Guillén, P. L</dc:creator>
<dc:creator>Mora Peris, B</dc:creator>
<dc:creator>Rodríguez González, T</dc:creator>
<dc:creator>Segovia Hernández, M</dc:creator>
<dc:creator>Martínez-Toldos, M. C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se ha estudiado la actividad de siete macrólidos, clindamicina y telitromicina frente a aislamientos clínicos del género Corynebacterium. Deéstos, 36 pertenecían a la especie C. jeikeium y 57 a C. amycolatum. Todos los macrólidos estudiados y la clindamicina presentaron escasaactividad, con CMI90 &gt;256 mg/l. La telitromicina presentó mejor actividad, siendo sensibles un 52,3% de C. amycolatum y un 70% de C.jeikeium resistentes a la eritromicina. El fenotipo de resistencia fue de tipo MLSb constitutivo en todos los aislamientos. El gen ermX fue detectadoen el 100% de las cepas resistentes a eritromicina, presentando una homología, en el caso de C. amycolatum, de un 100% con elde C. striatum y C. diptheriae</dc:description>
<dc:source>Rev Esp Quimioter;18(3): 236-242, jul.-sep. 2005. tab</dc:source>
<dc:identifier>ibc-042924</dc:identifier>
<dc:title xml:lang="es">Implicación de los genes ermX en la resistencia a los macrólidos y la telitromicina de Corynebacterium jeikeium y Corynebacterium amycolatum</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3368^s22021</dc:subject>
<dc:subject>^d33160</dc:subject>
<dc:subject>^d3368^s22052</dc:subject>
<dc:subject>^d24244^s22045</dc:subject>
<dc:subject>^d911^s22079</dc:subject>
<dc:subject>^d23201^s22079</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d32697^s22079</dc:subject>
<dc:subject>^d36322</dc:subject>
<dc:subject>^d28027^s22079</dc:subject>
<dc:type>article</dc:type>
<dc:date>200509</dc:date>
</metadata>
</record>
</ibecs-document>
